Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Fisher Scientific Expands Cryopreservation Reagents for Cell Culture

Published: Tuesday, January 08, 2013
Last Updated: Tuesday, January 08, 2013
Bookmark and Share
Thermo Scientific HyClone HyCryo and HyCryo-STEM advance cell recovery and viability for general cell culture and stem cell applications.

Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of cryopreservation reagents with the introduction of the Thermo Scientific HyClone HyCryo and HyCryo-STEM cryopreservation media, enabling researchers to maximize the preservation, recovery and growth of post-thaw cells for general cell culture and stem cell applications.

The new Thermo Scientific HyCryo™ media is a serum-free, animal component-free product intended for cryogenic preservation and storage of standard cell lines. Animal component-free assures the media is free of any human or animal non-human components to deliver better sample integrity and adaptability. Designed specifically for stem cell applications, Thermo Scientific HyCryo-STEM™ enhances cell recovery and post-thaw growth of pluripotent stem cells and neural progenitor cells. The serum-free formulation maintains differentiation potential and minimizes spontaneous differentiation of stem cells.

“Cell culture scientists that bank cell lines need the assurance that their cell lines are secure during cryogenic storage while maintaining their viability and integrity,” said Roberta Morris, business director, Thermo Fisher Scientific. “Our HyCryo formulation is designed to promote viability of frozen cells and ensure cellular integrity and recovery. Furthermore, HyCryo is a turnkey media solution, eliminating the added steps of mixing and filtering multiple products.”

HyCryo and HyCryo-STEM are designed to easily integrate into a researcher’s existing cell culture workflow and processes. Researchers can simply add the HyCryo cryopreservation media directly to prepared cells and transfer to a Thermo Scientific Nunc Cryovial for sample integrity during freezing and long-term storage.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Completes Sale of Cole-Parmer to GTCR
Thermo Fisher Scientific Inc. announced that it has completed the sale of its Cole-Parmer customer channel business to private equity firm GTCR LLC for approximately $480 million in cash.
Wednesday, August 20, 2014
Thermo to Sell Cole-Parmer for $480M
Company has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480 million in cash.
Monday, July 21, 2014
Thermo Completes Sale of Certain Assets to GE
Thermo has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare for $1.065 billion.
Monday, March 24, 2014
Thermo Completes Life Tech Acquisition
The completion of the transaction follows the receipt of all required regulatory approvals.
Tuesday, February 04, 2014
Thermo Scientific North Carolina Site Wins IndustryWeek’s Best Plant Award
Center of Excellence honored for exceptional performance, safety and processes.
Wednesday, January 15, 2014
Thermo Receives EC Clearance for Life Tech Acquisition
Thermo Fisher Scientific announced that it has received approval from the European Commission (EC) for its pending acquisition of Life Technologies Corporation.
Tuesday, November 26, 2013
Blood Banks Provide Vital Resource in Global Blood Supply Chain
Thermo Fisher installs 1000th blood banking centrifuge in India.
Monday, November 18, 2013
Thermo Scientific Offering to be Highlighted at ISSCR Stem Cell Research Symposium
The symposium highlights the latest Thermo Scientific tools and technologies available to researchers to advance their understanding of stem cells.
Tuesday, July 07, 2009
Thermo Fisher Scientific Sponsors Shanghai Conference on Stem Cell Research
Thermo Scientific sponsors the 2009 Shanghai Symposium of Stem Cell Research and Regenerative Medicine at the Shanghai Tong Ji University.
Thursday, May 14, 2009
Thermo Fisher Scientific to Highlight new Cell-based Technologies at ASCB 2008
The Company will showcase the latest tools and methods related to key mammalian cell-based research.
Friday, December 12, 2008
Thermo Fisher Scientific Sponsors Industry Symposia on Stem Cell Research
Symposium program will unveil new methods and technologies for stem cell scientists.
Tuesday, June 10, 2008
Thermo Fisher Scientific Launches New Cell Culture Excellence Program
The program is designed to provide essential products and services to address the daily challenges associated with culturing mammalian cells.
Tuesday, June 03, 2008
Scientific News
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Newfound Strength in Regenerative Medicine
A promising new approach uses direct mechanical stimulation to repair severely damaged skeletal muscles.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!